Tamoxifen in the Management of Breast Cancer: A Case Presented in Multidisciplinary Session With Clinical Discussion and Decision-Making

Background: Selective estrogen receptor modulators (SERMs) have been shown to reduce the risk of developing estrogen-positive breast cancer. Tamoxifen, a potent SERM, has been successfully administered as adjuvant therapy for breast cancer. However, uterine pathologic changes may develop due to the...

Full description

Bibliographic Details
Main Authors: Marziyeh Ghalamkari, Mohammadreza Tabary, Azam Tarafdari, Afsaneh Alikhassi, Farhad Shahi
Format: Article
Language:English
Published: Kaviani Breast Disease Institute 2019-02-01
Series:Archives of Breast Cancer
Subjects:
Online Access:https://archbreastcancer.com/index.php/abc/article/view/234